Trial
NCT02662894
Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
EMS
Collaborators
—
Condition
Hypertension
Intervention
Valsartan 160mg + Rosuvastatin 20mg
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-24